HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythropoietic protoporphyria. The problem of a suitable screening test.

Abstract
Erythropoietic protoporphyria (EPP) is characterized by increased red cell protoporphyrins and is included in the differential diagnosis of children presenting with photosensitivity. In the past 20 years, using the traditional solvent extraction qualitative screening test for blood porphyrins, the diagnosis of EPP had been missed in 9 out of 10 patients but recently, using fluorescence microscopy of erythrocytes, no patients with EPP have been missed. All 14 patients in Northern Ireland known to have EPP were recalled and it was found that fluorescence microscopic determination was positive in all cases. We recommend fluorescence microscopy as the screening test of choice for the detection of increased red cell porphyrins.
AuthorsD J Todd, G S Nesbitt, T D Lavery, E R Trimble, D Burrows
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 70 Issue 4 Pg. 347-50 ( 1990) ISSN: 0001-5555 [Print] Sweden
PMID1977265 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Protoporphyrins
Topics
  • Child
  • Child, Preschool
  • Erythrocytes (chemistry, pathology)
  • Female
  • Humans
  • Infant
  • Male
  • Microscopy, Fluorescence
  • Photosensitivity Disorders (diagnosis, genetics)
  • Porphyrias (diagnosis, genetics)
  • Protoporphyrins (blood)
  • Risk Factors
  • Skin Diseases (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: